| Physiologic changes in the heart following cessation of mechanical ventilation in a porcine model of donation after circulatory death: implications for cardiac transplantation CW White, R Lillico, J Sandha, D Hasanally, F Wang, E Ambrose, A Müller, ... American Journal of Transplantation 16 (3), 783-793, 2016 | 80 | 2016 |
| HDAC inhibitors induce global changes in histone lysine and arginine methylation and alter expression of lysine demethylases R Lillico, MG Sobral, N Stesco, TM Lakowski Journal of proteomics 133, 125-133, 2016 | 33 | 2016 |
| Disposition, metabolism and histone deacetylase and acetyltransferase inhibition activity of tetrahydrocurcumin and other curcuminoids JT Novaes, R Lillico, CL Sayre, K Nagabhushanam, M Majeed, Y Chen, ... Pharmaceutics 9 (4), 45, 2017 | 31 | 2017 |
| Selective DOT1L, LSD1, and HDAC class I inhibitors reduce HOXA9 expression in MLL-AF9 rearranged leukemia cells, but dysregulate the expression of many histone-modifying enzymes R Lillico, CK Lawrence, TM Lakowski Journal of proteome research 17 (8), 2657-2667, 2018 | 30 | 2018 |
| Absolute oral bioavailability of creatine monohydrate in rats: debunking a myth EA Alraddadi, R Lillico, JL Vennerstrom, TM Lakowski, DW Miller Pharmaceutics 10 (1), 31, 2018 | 23 | 2018 |
| Antimicrobial prophylaxis for patients undergoing cardiac surgery: intraoperative cefazolin concentrations and sternal wound infections SA Zelenitsky, D Calic, RC Arora, HP Grocott, TM Lakowski, R Lillico, ... Antimicrobial Agents and Chemotherapy 62 (11), 10.1128/aac. 01360-18, 2018 | 22 | 2018 |
| Evaluation of cefazolin antimicrobial prophylaxis during cardiac surgery with cardiopulmonary bypass D Calic, RE Ariano, RC Arora, HP Grocott, TM Lakowski, R Lillico, ... Journal of Antimicrobial Chemotherapy 73 (3), 768-771, 2018 | 19 | 2018 |
| Inhibitors of enzymes catalyzing modifications to histone lysine residues: structure, function and activity R Lillico, N Stesco, T Khorshid Amhad, C Cortes, MP Namaka, ... Future medicinal chemistry 8 (8), 879-897, 2016 | 19 | 2016 |
| Validation of cadherin HAV6 peptide in the transient modulation of the blood-brain barrier for the treatment of brain tumors BV Sajesh, NH On, R Omar, S Alrushaid, BM Kopec, WG Wang, HD Sun, ... Pharmaceutics 11 (9), 481, 2019 | 18 | 2019 |
| Quantification of cefazolin in serum and adipose tissue by ultra high performance liquid chromatography-Tandem mass spectrometry (UHPLC–MS/MS): Application to a pilot study of … R Lillico, CL Sayre, DS Sitar, NM Davies, CM Baron, TM Lakowski Journal of Chromatography B 1031, 94-98, 2016 | 18 | 2016 |
| Increased post-translational lysine acetylation of myelin basic protein is associated with peak neurological disability in a mouse experimental autoimmune encephalomyelitis … R Lillico, T Zhou, T Khorshid Ahmad, N Stesco, K Gozda, J Truong, ... Journal of Proteome Research 17 (1), 55-62, 2018 | 17 | 2018 |
| Pharmacokinetic Analysis of an Oral Multicomponent Joint Dietary Supplement (Phycox®) in Dogs SE Martinez, R Lillico, TM Lakowski, SA Martinez, NM Davies Pharmaceutics 9 (3), 30, 2017 | 13 | 2017 |
| Experimental autoimmune encephalomyelitis (EAE)-induced elevated expression of the E1 isoform of methyl CpG binding protein 2 (MeCP2E1): implications in multiple sclerosis (MS … T Khorshid Ahmad, T Zhou, K AlTaweel, C Cortes, R Lillico, TM Lakowski, ... International journal of molecular sciences 18 (6), 1254, 2017 | 12 | 2017 |
| The antioxidant activity of recombinant rat hepatic fatty acid binding protein T94A variant T Le, Y Gong, NM Davies, R Lillico, T Lakowski, MS Roberts, ... Journal of Pharmacy & Pharmaceutical Sciences 21 (1s), 309s-324s, 2018 | 2 | 2018 |
| Validation of Cadherin HAV6 Peptide in the Transient BV Sajesh, NH On, R Omar, S Alrushaid, WG Wang, HD Sun, R Lillico, ... Drug Delivery Technology Development in Canada, 23, 2019 | | 2019 |
| Overcoming off-target changes in gene expression by targeting epigenetic enzyme inhibitors to oncogenes using LNA-drug bioconjugates R Lillico | | 2019 |
| Joint Dietary Supplement (Phycox®) in Dogs SE Martinez, R Lillico, TM Lakowski, SA Martinez Pharmacokinetics and Drug Metabolism in Canada: The Current Landscape, 117, 2018 | | 2018 |
| PHA-739358 inhibitor R Lillico, CK Lawrence, TM Lakowski | | |
Ted M. LakowskiAssociate Professor and Director of the Pharmaceutical Analysis Laboratory, University of ManitobaEmail được xác minh tại ad.umanitoba.ca